Alessandro Vinceti

Alessandro Vinceti è dottorando presso il Centro di Biologia Computazionale dello Human Technopole. Ha conseguito una laurea in Biotecnologie presso l’Università di Modena e Reggio Emilia, seguita da un Master in Bioinformatica presso l’Università di Bologna.

Nell’ambito del suo dottorato di ricerca, Alessandro sta contribuendo allo sviluppo di strumenti per la correzione e l’analisi dei dati derivati da CRISPR-Cas9 screen basati su ampie coorti di linee cellulari tumorali umane immortalizzate. L’obiettivo è sfruttare le caratteristiche genetiche dei modelli tumorali per trovare bersagli terapeutici adatti che portino allo sviluppo/riproduzione del farmaco giusto per il paziente giusto, secondo i principi della medicina di precisione.


  • Twitter
  • LinkedIn


  • 07/2024 - Genome Biology

    A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening data

    Background CRISPR-Cas9 dropout screens are formidable tools for investigating biology with unprecedented precision and scale. However, biases in data lead to potential confounding effects on interpretation and compromise overall quality. The activity of Cas9 is influenced by structural features of the target site, including copy number amplifications (CN bias). More worryingly, proximal targeted loci tend […]

  • 01/2023 - Bioinformatics

    A heuristic algorithm solving the mutual-exclusivity sorting problem

    Motivation Binary (or boolean) matrices provide a common effective data representation adopted in several domains of computational biology, especially for investigating cancer and other human diseases. For instance, they are used to summarise genetic aberrations—copy number alterations or mutations—observed in cancer patient cohorts, effectively highlighting combinatorial relations among them. One of these is the tendency […]

  • 01/2023 - Cell Reports Methods

    An interactive web application for processing, correcting, and visualizing genome-wide pooled CRISPR-Cas9 screens

    A limitation of pooled CRISPR-Cas9 screens is the high false-positive rate in detecting essential genes arising from copy-number-amplified genomics regions. To solve this issue, we previously developed CRISPRcleanR: a computational method implemented as R/python package and in a dockerized version. CRISPRcleanR detects and corrects biased responses to CRISPR-Cas9 targeting in an unsupervised fashion, accurately reducing […]

  • 10/2022 - Nature

    Phenotypic plasticity and genetic control in colorectal cancer evolution

    Genetic and epigenetic variation, together with transcriptional plasticity, contribute to intratumour heterogeneity1. The interplay of these biological processes and their respective contributions to tumour evolution remain unknown. Here we show that intratumour genetic ancestry only infrequently affects gene expression traits and subclonal evolution in colorectal cancer (CRC). Using spatially resolved paired whole-genome and transcriptome sequencing, […]

  • 07/2022 - Cell Reports

    Reduced gene templates for supervised analysis of scale-limited CRISPR-Cas9 fitness screens

    Pooled genome-wide CRISPR-Cas9 screens are furthering our mechanistic understanding of human biology and have allowed us to identify new oncology therapeutic targets. Scale-limited CRISPR-Cas9 screens—typically employing guide RNA libraries targeting subsets of functionally related genes, biological pathways, or portions of the druggable genome—constitute an optimal setting for investigating narrow hypotheses and are easier to execute […]